Literature DB >> 16168615

Evaluation of Ochrobactrum intermedium bacteremia in a patient with bladder cancer.

Anucha Apisarnthanarak1, Pattarachai Kiratisin, Linda M Mundy.   

Abstract

It is generally believed that Ochrobactrum anthropi is the only pathogenic species in the genus Ochrobactrum. We report a case of presumptive Ochrobactrum intermedium bacteremia in a patient with bladder cancer. Identification of a rare species using rapid commercial panel could lead to an erroneous result as this clinical isolate was initially reported to be Shewanella putrefaciens. The patient was successfully treated with imipenem and ciprofloxacin.

Entities:  

Mesh：

Year:  2005        PMID： 16168615     DOI： 10.1016/j.diagmicrobio.2005.05.014

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  12 in total

1.  Phylogenetic profiling of bacterial community from two intimately located sites in Balramgari, North-East coast of India.

Authors:  Arvind Kumar Gupta; Ashraf Yusuf Rangrez; Pankaj Verma; Anil Chatterji; Yogesh S Shouche
Journal:  Indian J Microbiol       Date:  2009-06-10       Impact factor: 2.461

2.  Isolation and characterization of a crude oil degrading bacteria from formation water: comparative genomic analysis of environmental Ochrobactrum intermedium isolate versus clinical strains.

Authors:  Lu-jun Chai; Xia-wei Jiang; Fan Zhang; Bei-wen Zheng; Fu-chang Shu; Zheng-liang Wang; Qing-feng Cui; Han-ping Dong; Zhong-zhi Zhang; Du-jie Hou; Yue-hui She
Journal:  J Zhejiang Univ Sci B       Date:  2015-10       Impact factor: 3.066

3.  Insights into the evolution of sorbitol metabolism: phylogenetic analysis of SDR196C family.

Authors:  Agustín Sola-Carvajal; María Inmaculada García-García; Francisco García-Carmona; Álvaro Sánchez-Ferrer
Journal:  BMC Evol Biol       Date:  2012-08-16       Impact factor: 3.260

4.  A treatment plant receiving waste water from multiple bulk drug manufacturers is a reservoir for highly multi-drug resistant integron-bearing bacteria.

Authors:  Nachiket P Marathe; Viduthalai R Regina; Sandeep A Walujkar; Shakti Singh Charan; Edward R B Moore; D G Joakim Larsson; Yogesh S Shouche
Journal:  PLoS One       Date:  2013-10-29       Impact factor: 3.240

5.  Ochromobactrum intermedium: an emerging opportunistic pathogen-case of recurrent bacteraemia associated with infective endocarditis in a haemodialysis patient.

Authors:  T Bharucha; D Sharma; H Sharma; H Kandil; S Collier
Journal:  New Microbes New Infect       Date:  2016-10-06

6.  The first case of Ochrobactrum intermedium bacteremia in a pediatric patient with malignant tumor.

Authors:  Wenjing Wu; Yongmei Jiang; Wei Zhou; Xingxin Liu; Linghan Kuang
Journal:  BMC Infect Dis       Date:  2021-12-14       Impact factor: 3.090

7.  Genomics of Ochrobactrum pseudogrignonense (newly named Brucella pseudogrignonensis) reveals a new bla OXA subgroup.

Authors:  Shu-Yuan Li; Yin-En Huang; Jhih-Yang Chen; Chung-Hsu Lai; Yan-Chiao Mao; Yao-Ting Huang; Po-Yu Liu
Journal:  Microb Genom       Date:  2021-08

8.  Draft genome of Ochrobactrum intermedium strain M86 isolated from non-ulcer dyspeptic individual from India.

Authors:  Girish Kulkarni; Dhiraj Dhotre; Mahesh Dharne; Sudarshan Shetty; Somak Chowdhury; Vatsala Misra; Sriprakash Misra; Milind Patole; Yogesh Shouche
Journal:  Gut Pathog       Date:  2013-04-04       Impact factor: 4.181

9.  Epidemiology of bacteremia caused by uncommon non-fermentative gram-negative bacteria.

Authors:  Pinyo Rattanaumpawan; Prapassorn Ussavasodhi; Pattarachai Kiratisin; Nalinee Aswapokee
Journal:  BMC Infect Dis       Date:  2013-04-08       Impact factor: 3.090

10.  Intravitreal moxifloxacin in the management of Ochrobactrum intermedium endophthalmitis due to metallic intraocular foreign body.

Authors:  David J Jacobs; Thomas J Grube; Harry W Flynn; Craig M Greven; Avinash Pathengay; Darlene Miller; Robert F Sanke; Joseph Thorman
Journal:  Clin Ophthalmol       Date:  2013-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.